Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001047469-05-006578
Filing Date
2005-03-15
Accepted
2005-03-15 17:19:06
Documents
10
Period of Report
2004-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K a2153502z10-k.htm 10-K 544472
2 EXHIBIT 21.1 a2153502zex-21_1.htm EX-21.1 2167
3 EXHIBIT 23.1 a2153502zex-23_1.htm EX-23.1 2364
4 EXHIBIT 31.1 a2153502zex-31_1.htm EX-31.1 5575
5 EXHIBIT 31.2 a2153502zex-31_2.htm EX-31.2 5581
6 EXHIBIT 32.1 a2153502zex-32_1.htm EX-32.1 4122
7 G381142.JPG g381142.jpg GRAPHIC 48996
8 G620377.JPG g620377.jpg GRAPHIC 69584
9 G876837.JPG g876837.jpg GRAPHIC 33690
10 G166230.JPG g166230.jpg GRAPHIC 68548
  Complete submission text file 0001047469-05-006578.txt   787809
Mailing Address 125 SUMMER STREET BOSTON MA 02110
Business Address 125 SUMMER STREET BOSTON MA 02110 6179332130
POINT THERAPEUTICS INC (Filer) CIK: 0000919745 (see all company filings)

EIN.: 043216862 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-23776 | Film No.: 05682584
SIC: 2834 Pharmaceutical Preparations